Laparoscopic spectral analysis of endometriosis.
OBJECTIVE
To determine if lesions of endometriosis will preferentially absorb light of the blue spectrum thus enabling the detection of nonvisualized disease.


METHODS
Retrospective analysis (Canadian Task Force classification II-2).


METHODS
University based teaching hospital.


METHODS
Twenty-five women with pain suggestive of endometriosis.


METHODS
A noninvasive technique was employed to better visualize lesions of endometriosis at time of diagnostic laparoscopy.


RESULTS
A Storz PDD light source, which delivers a blue light at a specified frequency of 440 Hz, was used concurrently with full-spectrum white light. A Storz PDD laparoscope, which utilizes filters to detect the blue spectrum of light, was then coupled to the blue-light source. Lesions of endometriosis were compared using standard white light to that of blue light. The new lesions seen using blue light were sampled to confirm pathology. Using standard white light, black, red, and clear lesions were identified, and the borders of the lesions were marked. The same lesions were observed using the blue spectrum of light. The lesions absorbed blue light, but nonvisible endometriosis surrounding the classic lesions were also identified. Biopsies confirmed endometriosis in newly visible lesions.


CONCLUSIONS
Lesions of endometriosis preferentially absorb the blue-light spectrum. Laparoscopic spectral analysis enables visualization of previously nonvisible endometriosis and makes other visible lesions easier to identify.
Demco
Larry
L
University of Calgary, Calgary, Canada.
D000328:Adult; D001707:Biopsy, Needle; D002908:Chronic Disease; D004715:Endometriosis / Q000175:diagnosis* / Q000473:pathology; D005260:Female; D005336:Fiber Optic Technology; D006801:Humans; D007150:Immunohistochemistry; D010535:Laparoscopy / Q000379:methods*; D008875:Middle Aged; D017699:Pelvic Pain / Q000175:diagnosis* / Q000209:etiology; D010537:Peritoneum / Q000473:pathology*; D012189:Retrospective Studies; D012494:Sampling Studies; D012680:Sensitivity and Specificity; D012720:Severity of Illness Index; D013050:Spectrometry, Fluorescence